Literature DB >> 21716071

HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization.

Ivan Landires1, Florence Bugault, Olivier Lambotte, Pierre de Truchis, Laurence Slama, Anne Danckaert, Jean-François Delfraissy, Jacques Thèze, Lisa A Chakrabarti.   

Abstract

OBJECTIVE: Interleukin-7 (IL-7) responses are impaired in CD4(+) T cells from HIV-infected patients, which may play a significant role in the loss of CD4(+) T-cell homeostasis. We set to investigate the nature of IL-7-dependent signaling defects in patients with progressive HIV-1 infection. DESIGN AND METHODS: IL-7 signaling was compared in CD4(+) T cells from viremic patients with a viral load more than 10,000 copies of HIV RNA/ml (n = 23) and from healthy blood donors (n = 23). Phosphorylation of the transcription factor STAT5 on the regulatory serine S726 and the key tyrosine Y694 was monitored by intracellular flow cytometry. Phospho-STAT5 relocalization to the nucleus was analyzed by quantitative immunofluorescence imaging.
RESULTS: In control CD4(+) T cells, S726 phosphorylation was mostly constitutive and inducible by IL-7 to a limited extent (1.3x, P < 0.05). In contrast, phosphorylation at Y694 was highly inducible by IL-7 (12.6x, P < 0.0001). Progressive HIV infection led to hyperphosphorylation of both S726 and Y694 in naive CD4(+) T cells, with these changes correlating together (R = 0.66, P = 0.01). Quantitative image analysis revealed an impairment in the nuclear relocalization of both forms of phospho-STAT5 in patient cells (P < 0.005 for S726; P < 0.05 for Y694). The nuclear relocalization defect correlated with increased HLA-DR expression (R = 0.75, P < 0.01), suggesting a role for chronic immune activation in perturbed IL-7 signal transduction.
CONCLUSION: HIV infection perturbs IL-7 signaling by impairing the access of STAT5 to the nuclear compartment. This defect may contribute to the loss of CD4(+) T-cell populations in patients with chronically high immune activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716071     DOI: 10.1097/QAD.0b013e32834a3678

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

Review 1.  The role of cytokines in the pathogenesis and treatment of HIV infection.

Authors:  Marta Catalfamo; Cecile Le Saout; H Clifford Lane
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-26       Impact factor: 7.638

2.  PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients.

Authors:  Julien Pothlichet; Thierry Rose; Florence Bugault; Louise Jeammet; Annalisa Meola; Ahmed Haouz; Frederick Saul; David Geny; José Alcami; Ezequiel Ruiz-Mateos; Luc Teyton; Gérard Lambeau; Jacques Thèze
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 3.  Foxo3a: an integrator of immune dysfunction during HIV infection.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Sandrina DaFonseca; Talibah Metcalf; Cecile L Tremblay; Lydie Trautmann; Rafick-Pierre Sekaly; John Schatzle; Elias K Haddad
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

4.  HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127.

Authors:  Rebecca B Hasley; Changwan Hong; Wenqing Li; Travis Friesen; Yoriko Nakamura; Grace Y Kim; Jung-Hyun Park; Julie A Hixon; Scott Durum; Zonghui Hu; Michael C Sneller; Raphael Oguariri; Tomozumi Imamichi; H Clifford Lane; Marta Catalfamo
Journal:  AIDS       Date:  2013-07-31       Impact factor: 4.177

Review 5.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

6.  Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control.

Authors:  Aaruni Khanolkar; William J Muller; Bridget M Simpson; Jillian Cerullo; Ruth Williams; Sun Bae Sowers; Kiana Matthews; Sara Mercader; Carole J Hickman; Richard T D'Aquila; Guorong Liu
Journal:  Commun Med (Lond)       Date:  2022-03-04

7.  Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy.

Authors:  Benjamin Krämer; Felix Goeser; Philipp Lutz; Andreas Glässner; Christoph Boesecke; Carolynne Schwarze-Zander; Dominik Kaczmarek; Hans Dieter Nischalke; Vittorio Branchi; Steffen Manekeller; Robert Hüneburg; Tobias van Bremen; Tobias Weismüller; Christian P Strassburg; Jürgen K Rockstroh; Ulrich Spengler; Jacob Nattermann
Journal:  PLoS Pathog       Date:  2017-05-15       Impact factor: 6.823

8.  Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis.

Authors:  Christian Lundtoft; Anthony Afum-Adjei Awuah; Jens Rimpler; Kirstin Harling; Norman Nausch; Malte Kohns; Ernest Adankwah; Franziska Lang; Laura Olbrich; Ertan Mayatepek; Ellis Owusu-Dabo; Marc Jacobsen
Journal:  PLoS Pathog       Date:  2017-06-05       Impact factor: 6.823

9.  Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.

Authors:  Alberto Bosque; Kyle A Nilson; Amanda B Macedo; Adam M Spivak; Nancie M Archin; Ryan M Van Wagoner; Laura J Martins; Camille L Novis; Matthew A Szaniawski; Chris M Ireland; David M Margolis; David H Price; Vicente Planelles
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

10.  Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness.

Authors:  Anne P Bouvy; Mariska Klepper; Michiel G H Betjes; Willem Weimar; Dennis A Hesselink; Carla C Baan
Journal:  Transplant Direct       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.